Medpace
Research in Johannesburg

Medpace Inc. is a clinical research organization and drug and medical device development service, critical to the advancement of global clinical trials.

is to accelerate the global development of safe and effective medical therapeutics. Our unique global partnering philosophy emphasizes an uncompromising commitment to clinical research and to the highest level of ethical standards and performance in our jobs. We are selective about the projects we engage in because we are devoted to quality and providing our partners with best-in-class service. Long-standing relationships with sponsors demonstrates how our full-service outsourcing model delivers higher quality results. We asked our Sponsors why they chose Medpace as their clinical development partner. Our therapeutically-aligned scientific expertise provides deep insights and leadership throughout the project. Our full-service model and solution-oriented project teams deliver consistent and high-quality trial execution. Medpace has the global reach to conduct biopharmaceutical and medical device studies around the world. With coverage across six continents, Medpace has the global expertise and experience to proactively plan and execute trials of all sizes. Our medical, operational, and regulatory specialists have country-specific expertise which allows them to acquire a deeper understanding of the importance of local language, culture, and processes. By being embedded in the culture, we can create better relationships with investigators, deliver faster enrollment timelines, and obtain access to the country specific patient populations. Medpace is the only global CRO with a fully integrated Clinical Research Campus. Dallas, TX is home to a clinical operations office where staff are located in the hub of an active and growing life science cluster. The Cambridge, MA office is located in a hot bed of biotechnology, pharmaceutical and medical device sponsors. Minneapolis, MN is home to our Medical Device headquarters, the number one medical device ecosystem in the country. With well-developed medical and healthcare systems, and an experienced and mature site infrastructure for conducting clinical trials, the European Union (EU), Central and Eastern Europe (CEE), and Israel combine to be an advantageous landscape for conducting clinical research. Extensive site database with corresponding performance metrics enables quick identification of high quality sites facilitating access to patients. In-house regulatory expertise that covers the full array of medicinal products & routes of administration, from NCEs to biologicals & ATMPs. Presence in the region includes the support by local offices, global central laboratory (Belgium), and imaging capabilities (France) Asia-Pacific countries offer access to large patient populations for local clinical studies, as well as large global studies. Well-profiled networks of sites across multiple therapeutic areas. Experienced staff with country-specific expertise and site relationships. Specialized experience in China supporting sponsors with scientific and regulatory guidance for early phase clinical development. Clinical trials have been conducted in Latin America for over 25 years and is becoming an increasingly important region for conducting research. Offices in Argentina, Brazil, Mexico, and operational partners in Peru, Colombia, and Central America. Access to qualified, reliable, committed and experienced healthcare professionals with culturally stronger patient-physician relationships that facilitates enrollment and adherence. Medpace opened an office in Johannesburg, South Africa in 2006, providing the ideal base to manage and monitor studies in other central and southern African countries. Experience conducting multiple studies in a variety of indications. Knowledge of the various regulatory requirements of South African countries.